Menu
  • Home
  • Contact Us

A New Startup Wants to Use Crispr to Diagnose Disease

A New Startup Wants to Use Crispr to Diagnose Disease
May 4, 2018
Investments

In 2011, biologists Jennifer Doudna and Emmanuelle Charpentier published a landmark paper introducing the world to Crispr. The arcane family of bacterial proteins had a talent for precisely snipping DNA, and one of them—Cas9—has since inspired a billion-dollar boom Continue reading →

Investments
crispr, DNA, genetics, Health, Science

Crispr Therapeutics Plans Its First Clinical Trial for Genetic Disease

Crispr Therapeutics Plans Its First Clinical Trial for Genetic Disease
December 18, 2017
Investments

In late 2012, French microbiologist Emmanuelle Charpentier approached a handful of American scientists about starting a company, a Crispr company. They included UC Berkeley’s Jennifer Doudna, George Church at Harvard University, and his former postdoc Feng Zhang of the Broad Continue reading →

Investments
crispr, gene therapy, genetics, Science

Sitemap | Home | Disclaimer | Privacy Policy | Terms of Use | Investment Courses South Africa